McKesson Co. (MCK) Shares Sold by Acropolis Investment Management LLC

Acropolis Investment Management LLC cut its stake in McKesson Co. (NYSE:MCK) by 19.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,690 shares of the company’s stock after selling 402 shares during the period. Acropolis Investment Management LLC’s holdings in McKesson were worth $187,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Nordea Investment Management AB grew its position in shares of McKesson by 48.8% in the third quarter. Nordea Investment Management AB now owns 3,300,839 shares of the company’s stock valued at $437,856,000 after purchasing an additional 1,082,398 shares during the last quarter. Pzena Investment Management LLC grew its position in shares of McKesson by 11.4% in the third quarter. Pzena Investment Management LLC now owns 3,160,195 shares of the company’s stock valued at $419,200,000 after purchasing an additional 323,485 shares during the last quarter. Baupost Group LLC MA grew its position in shares of McKesson by 33.7% in the third quarter. Baupost Group LLC MA now owns 2,175,700 shares of the company’s stock valued at $288,607,000 after purchasing an additional 548,000 shares during the last quarter. Kiltearn Partners LLP grew its position in shares of McKesson by 9.1% in the third quarter. Kiltearn Partners LLP now owns 2,040,651 shares of the company’s stock valued at $270,692,000 after purchasing an additional 170,753 shares during the last quarter. Finally, American Century Companies Inc. grew its position in shares of McKesson by 13.6% in the third quarter. American Century Companies Inc. now owns 1,735,496 shares of the company’s stock valued at $230,214,000 after purchasing an additional 207,533 shares during the last quarter. 85.31% of the stock is owned by institutional investors.

MCK has been the topic of several research reports. Morgan Stanley lowered their price target on shares of McKesson from $142.00 to $130.00 in a research report on Sunday, December 9th. Barclays lowered their price target on shares of McKesson from $150.00 to $136.00 and set an “equal weight” rating on the stock in a research report on Friday, October 26th. Royal Bank of Canada set a $155.00 price target on shares of McKesson and gave the company a “hold” rating in a research report on Friday, October 26th. Zacks Investment Research upgraded shares of McKesson from a “sell” rating to a “hold” rating in a research report on Wednesday. Finally, ValuEngine upgraded shares of McKesson from a “strong sell” rating to a “sell” rating in a research report on Monday, October 29th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and six have issued a buy rating to the company. The company has an average rating of “Hold” and an average target price of $144.30.

Shares of NYSE MCK opened at $122.04 on Friday. McKesson Co. has a 1 year low of $106.11 and a 1 year high of $178.86. The company has a market cap of $22.34 billion, a P/E ratio of 9.67, a PEG ratio of 1.30 and a beta of 1.06. The company has a current ratio of 0.99, a quick ratio of 0.56 and a debt-to-equity ratio of 0.69.

McKesson (NYSE:MCK) last announced its earnings results on Thursday, October 25th. The company reported $3.60 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $3.28 by $0.32. McKesson had a net margin of 0.06% and a return on equity of 26.55%. The firm had revenue of $53.08 billion for the quarter, compared to analyst estimates of $53.56 billion. Sell-side analysts anticipate that McKesson Co. will post 13.41 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Wednesday, January 2nd. Investors of record on Monday, December 3rd were given a dividend of $0.39 per share. The ex-dividend date of this dividend was Friday, November 30th. This represents a $1.56 dividend on an annualized basis and a yield of 1.28%. McKesson’s dividend payout ratio (DPR) is currently 12.36%.

ILLEGAL ACTIVITY NOTICE: This piece of content was first posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of international trademark & copyright legislation. The legal version of this piece of content can be accessed at https://www.chaffeybreeze.com/2019/01/11/mckesson-co-mck-shares-sold-by-acropolis-investment-management-llc.html.

McKesson Profile

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.

Read More: What are Institutional Investors?

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply